Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-02-25 @ 5:45 PM
Study NCT ID:
NCT00726466
Status:
WITHDRAWN
Last Update Posted:
2015-07-07
First Post:
2008-07-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration
Sponsor:
Vitreous -Retina- Macula Consultants of New York
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FVF4385s
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Jason S. Slakter, MD
Old Organization:
Vitreous Retina Macula Consultants of New York
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |